Xu Jiandong
SEC insider (Form 3/4/5 filer). CIK 0001920399. Chief Financial Officer at Estrella Immunopharma, Inc. (ESLA) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in EMERYVILLE, CA.
Companies Xu Jiandong has filed insider reports for
- Estrella Immunopharma, Inc. (ESLA): Officer, Chief Financial Officer
- Denali Capital Acquisition Corp. (DECA): 10% Owner
Xu Jiandong
CIK: 0001920399
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 18, 2026ESLA
Estrella Immunopharma, Inc.
ExerciseDirect100K shares at avg. $0.81$82K - Oct 7, 2025ESLA
Estrella Immunopharma, Inc.
PurchaseDirect1K shares at avg. $1.33$1K - Sep 22, 2025ESLA
Estrella Immunopharma, Inc.
PurchaseIndirect1K shares at avg. $1.16$1K - Sep 11, 2025ESLA
Estrella Immunopharma, Inc.
PurchaseDirect100 shares at avg. $1.04$104 - Oct 30, 2024ESLA
Estrella Immunopharma, Inc.
AwardDirectIncentive Share Option
490.8K shares- - Oct 30, 2024ESLA
Estrella Immunopharma, Inc.
AwardDirectNonstatutory Share Option
509.2K shares- - Aug 30, 2024DECA
Denali Capital Acquisition Corp.
SaleIndirectClass B Ordinary Shares
500K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 18, 2026 |  ESLA Estrella Immunopharma, Inc. | Exercise | 100,000 | $0.81 | $81,500 | Direct |
| Oct 7, 2025 | ESLA Estrella Immunopharma, Inc. | Purchase | 1,000 | $1.33 | $1,330 | Direct |
| Sep 22, 2025 | ESLA Estrella Immunopharma, Inc. | Purchase | 1,000 | $1.16 | $1,160 | Indirect |
| Sep 11, 2025 | ESLA Estrella Immunopharma, Inc. | Purchase | 100 | $1.04 | $104 | Direct |
| Oct 30, 2024 | ESLA Estrella Immunopharma, Inc. | Award Incentive Share Option | 490,796 | - | - | Direct |
| Oct 30, 2024 | ESLA Estrella Immunopharma, Inc. | Award Nonstatutory Share Option | 509,204 | - | - | Direct |
| Aug 30, 2024 |  DECA Denali Capital Acquisition Corp. | Sale Class B Ordinary Shares | 500,000 | - | - | Indirect |
1-7 of 7 transactions